An MRI-based system that delivers radiation therapy to cancer patients has received 510(k) clearance from the U.S. Food and Drug Administration. It’s a “major milestone” for Cleveland-area ViewRay, which in March closed on the last tranche of a $45 million series C investment round, according to a statement from the company. The designation from the […]
A company that’s developing MRI-based technology to deliver radiation therapy to cancer patients has closed the last tranche of a $45 million series C round of investment as it nears commercialization. Cleveland-area ViewRay is preparing for market launch. The company’s imaging and radiotherapy-delivery system is awaiting 510(k) regulatory clearance by the U.S. Food and Drug […]
A company that’s developing MRI-based technology to deliver radiation therapy to cancer patients has secured $10 million in new investment funding. Oakwood Village, Ohio-based ViewRay‘s $10.3 million fundraise comes from existing investors, according to a document filed with U.S. Securities and Exchange Commission. Investors listed in the document include Kearny Venture Partners, OrbiMed Advisors, Fidelity […]
